" /> UPR1024 - CISMeF





Preferred Label : UPR1024;

MeSH note : UPR1024 or its derivatives might serve as drugs for the treatment of lung cancer in patients resistant to classic tyrosine kinase inhibitors; structure in first source;

Is substance : O;

Détails


Vous pouvez consulter :


Nous contacter.
27/07/2025


[Accueil] [Haut de page]

© CHU de Rouen. Toute utilisation partielle ou totale de ce document doit mentionner la source.